Showing results (11-20 of 165) with videos related to
Sort By:
Pageof 17
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Hepatocellular carcinoma in viral hepatitis: improving standard therapyRyota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, et al.Oncology|March 1, 2002
Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablationShuichiro Shiina, Takuma Teratani, Shuntaro Obi, et al.Nutrients|December 28, 2021
Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score AnalysisHironao Okubo, Hitoshi Ando, Eisuke Nakadera, et al.Hepato-Gastroenterology|March 24, 2005
Three-dimensional power Doppler ultrasonography for hepatocellular carcinoma: a comparison with angiography?Shinpei Sato, Haruhiko Yoshida, Takuma Teratani, et al.Journal of Clinical Microbiology|August 31, 2002
Weak association between SEN virus viremia and liver diseaseHideo Yoshida, Naoya Kato, Yasushi Shiratori, et al.Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular CarcinomaHironao Okubo, Hitoshi Ando, Yusuke Takasaki, et al.Scientific Reports|June 1, 2019
Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular CarcinomaMasaya Sato, Kentaro Morimoto, Shigeki Kajihara, et al.AJR. American Journal of Roentgenology|September 23, 2009
Percutaneous radiofrequency ablation of hepatocellular carcinoma in 14 patients undergoing regular hemodialysis for end-stage renal diseaseYuji Kondo, Haruhiko Yoshida, Yutaka Tomizawa, et al.Journal of Pharmacological Sciences|December 20, 2021
Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinomaHironao Okubo, Hitoshi Ando, Kei Ishizuka, et al.Hepato-Gastroenterology|May 9, 2002
Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinomaYujin Hoshida, Yasushi Shiratori, Yukihiro Koike, et al.Pageof 17